GlaxoSmithKline plc (GSK) |
|
39.46 0.12 (0.31%)
|
05-17 16:02 |
|
Open: |
39.27 |
Pre. Close: |
39.34 |
|
High:
|
39.68 |
Low:
|
39.27 |
|
Volume:
|
1,924,392 |
Market Cap:
|
100335M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
39.715 - 39.994 |
39.994 - 40.212 |
|
Low:
|
38.74 - 39.041 |
39.041 - 39.274 |
|
Close:
|
39.072 - 39.532 |
39.532 - 39.889 |
|
|
|
Technical analysis |
as of: 2019-05-17 4:28:57 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 47.14  One year: 48.07 |
| Support: |
Support1: 39.07 Support2: 32.51 |
| Resistance: |
Resistance1: 40.36 Resistance2: 41.16 |
| Pivot: |
39.95 |
| Moving Average: |
MA(5): 39.39 MA(20): 39.98
MA(100): 40.03 MA(250): 40.13 |
| MACD: |
MACD(12,26): -0.35 Signal(9): -0.30 |
| Stochastic oscillator: |
%K(14,3): 18.66 %D(3): 16.00 |
| RSI: |
RSI(14): 40.75 |
| 52-week: |
High: 42.36 Low: 36.41 Change(%): -1.4 |
| Average Vol(K): |
3-Month: 240275 10-Days: 228766 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.GSK has closed above bottom band by 29.4%. Bollinger Bands are 21.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 17 May 2019 15:19:04 Z
Thermo Fisher Acquires GlaxoSmithKline's Drug Production Site
Wed, 08 May 2019 17:54:51 Z
Theravance (TBPH) Q1 Loss Widens, Revenues Miss Estimates
Wed, 08 May 2019 15:51:13 Z
Clovis (CLVS) Q1 Earnings Top Estimates, Rubraca Sales Strong
Tue, 07 May 2019 23:13:46 Z
What's in Store for Axsome (AXSM) This Earnings Season?
Mon, 06 May 2019 15:17:06 Z
The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Major |
| Shares Out. (M) |
2493.89 |
| Shares Float (M) |
2493.89 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
12.60 |
|
Shares Short (K)
|
7588 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
3.070 |
|
EPS Est. Current Year
|
2.890 |
|
EPS Est. Next Year
|
2.850 |
|
EPS Est. Next Quarter
|
|
|
Forward EPS
|
2.930 |
|
Book Value (p.s.)
|
17.220 |
|
PEG Ratio
|
1.43 |
|
Profit Margin
|
13.67 |
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
6.9 |
|
Return on Equity (ttm)
|
-5658.0 |
|
Qtrly Rev. Growth
|
6.1 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
51.20 |
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
P/E
|
12.85 |
|
P/E Growth Ratio
|
|
|
P/BV
|
2.29 |
|
P/S
|
|
|
P/CF
|
|
Dividends & Splits |
|
Dividend
|
5.012 |
|
Dividend Yield
|
0.13 |
|
Dividend Pay Date
|
2019-07-11 |
|
Ex-Dividend Date
|
2019-05-16 |
|
Forward Dividend
|
2.390 |
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
